BIOMAT Database Logo BIOMAT Database Logo

Characterization of dipeptidyl peptidase IV (CD26) from human lymphocytes. 1992

I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Department of Clinical Biochemistry, Faculty of Medicine, University of Antwerp, Wilrijk, Belgium.

The membrane-bound dipeptidyl peptidase IV (DPP IV, EC 3.4.14.5) has been purified 5,400-fold from human peripheral blood mononuclear cells. The purification procedure included detergent solubilization and successive chromatography on DEAE Sepharose Fast Flow, Con A Sepharose, Cu2+ loaded metal-chelating Sepharose, Sephacryl S-300 High Resolution and Q Sepharose Hiload. The molecular mass of the native, detergent solubilized enzyme estimated by gel filtration was 264.kDa. Chromatofocusing indicated a pI of approximately 5.0. The pI optimum was 8.7. The enzymatic activity of the purified preparation was irreversibly inhibited by N-(H-Phe-Pro)-O-(4-nitrobenzoyl)hydroxylamine hydrochloride in the micromolar range. The binding of purified DPP IV to CD26 monoclonal antibodies confirmed the identity between CD26 and dipeptidyl peptidase IV. The purification and characterization of lymphocytic dipeptidyl peptidase IV is of great value for the identification of its natural substrates and for the study of its physiological significance in the T-lymphocyte function.

UI MeSH Term Description Entries
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D007526 Isoelectric Point The pH in solutions of proteins and related compounds at which the dipolar ions are at a maximum. Isoelectric Points,Point, Isoelectric,Points, Isoelectric
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002845 Chromatography Techniques used to separate mixtures of substances based on differences in the relative affinities of the substances for mobile and stationary phases. A mobile phase (fluid or gas) passes through a column containing a stationary phase of porous solid or liquid coated on a solid support. Usage is both analytical for small amounts and preparative for bulk amounts. Chromatographies
D004152 Dipeptidyl-Peptidases and Tripeptidyl-Peptidases A subclass of exopeptidases that includes enzymes which cleave either two or three AMINO ACIDS from the end of a peptide chain. Dipeptidyl Peptidase,Dipeptidyl Peptidases,Dipeptidylpeptide Hydrolase,Tripeptidyl-Peptidase,Dipeptidylpeptide Hydrolases,Tripeptidyl-Peptidases,Dipeptidyl Peptidases and Tripeptidyl Peptidases,Hydrolase, Dipeptidylpeptide,Peptidase, Dipeptidyl,Tripeptidyl Peptidase,Tripeptidyl Peptidases,Tripeptidyl-Peptidases and Dipeptidyl-Peptidases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
September 1998, European journal of biochemistry,
I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Mechanisms of CD26/dipeptidyl peptidase IV cytokine-dependent regulation on human activated lymphocytes.
July 2000, Cytokine,
I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes.
June 1991, Scandinavian journal of immunology,
I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Cellular expression of CD26/dipeptidyl peptidase IV.
January 2021, Biomedical research (Tokyo, Japan),
I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Interleukin-12 enhances CD26 expression and dipeptidyl peptidase IV function on human activated lymphocytes.
November 1997, Immunobiology,
I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Expression of CD26 (dipeptidyl peptidase IV) on memory and naive T lymphocytes.
May 1992, Scandinavian journal of immunology,
I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.
October 1991, Journal of immunology (Baltimore, Md. : 1950),
I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Expression, purification, and characterization of human dipeptidyl peptidase IV/CD26 in Sf9 insect cells.
August 2002, Protein expression and purification,
I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Aberrant dipeptidyl peptidase IV (DPP IV/CD26) expression in human hepatocellular carcinoma.
August 1997, Journal of hepatology,
I De Meester, and G Vanhoof, and D Hendriks, and H U Demuth, and A Yaron, and S Scharpé
Metabolism of glucagon by dipeptidyl peptidase IV (CD26).
January 2001, Regulatory peptides,
Copied contents to your clipboard!